Foundation For Angelman Syndrome Therapeutics
| Year | Money in | Money out | Result | Reserve mo. | Staffing |
|---|---|---|---|---|---|
| 2020 | $9,357,654 | $3,052,395 | $6,305,259 | 62.6 | 9% |
| 2021 | $3,977,487 | $5,835,365 | −$1,857,878 | 29.6 | 10% |
| 2022 | $52,477,819 | $8,933,021 | $43,544,798 | 75.0 | 10% |
| 2023 | $6,525,815 | $23,229,158 | −$16,703,343 | 20.6 | 6% |
In its most recent public year (2023), this organization spent $16,703,343 more than it brought in. Its reserves stood at about 20.6 months of spending, down from 62.6 in 2020. Staff pay was 6% of spending. $15,457 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings ↗
Be told when its next filing posts
No account, no email address. A new entry appears through a feed — the quiet technology behind podcasts — that you can add to a reader, Slack, or any automation tool. How following works ↗